Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

The COVID-19 pandemic affected hair restoration practices in 2022.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.

During COVID-19, Iraqi women experienced more hair loss and skin issues like acne, likely due to stress and mask-wearing.

Long-COVID can cause lasting symptoms, but treatment with Erbisol drugs may help.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.

Topical Minoxidil is effective for hair loss after COVID-19.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

A team of different healthcare experts is good for treating long-term COVID-19 issues.

Understanding and managing long-term COVID-19 effects is crucial.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Testosterone's effects on COVID-19 are unclear and need more research.